SCHEMBL6989884

SCHEMBL6989884

CC(N)(CC/C(F)=C\CNCC=N)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GGT1 P19440 1/20 0.36
ARG1 P05089 1/20 0.33
ARG2 P78540 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6989888 1.00 GGT1 (0.36) GGT1ARG1ARG2
SCHEMBL6989839 1.00 GGT1 (0.36) GGT1ARG1ARG2
SCHEMBL6988281 1.00 GGT1 (0.36) GGT1ARG1ARG2
SCHEMBL6989843 1.00 GGT1 (0.36) GGT1ARG1ARG2
SCHEMBL6988958 1.00 GGT1 (0.36) GGT1ARG1ARG2
SCHEMBL6988278 1.00 GGT1 (0.36) GGT1ARG1ARG2
SCHEMBL6990294 0.88 GGT1 (0.31) GGT1
SCHEMBL6989714 0.84 GGT1 (0.37) GGT1ARG1ARG2
SCHEMBL6990128 0.83 GGT1 (0.34) GGT1ARG1ARG2
SCHEMBL6990121 0.83 GGT1 (0.34) GGT1ARG1ARG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317421-A1 2-AMINO-2-ALKYL-5 HEPTENOIC AND HEPTYNOIC ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS Pharmacia Corporation (US) 2003-06-11 EP claimed
WO-2002022562-A1 2-AMINO-2-ALKYL-5 HEPTENOIC AND HEPTYNOIC ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS PHARMACIA CORPORATION (US) 2002-03-21 WO claimed
EP-1317421-A1 2-AMINO-2-ALKYL-5 HEPTENOIC AND HEPTYNOIC ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS Pharmacia Corporation (US) 2003-06-11 EP disclosed
WO-2002022562-A1 2-AMINO-2-ALKYL-5 HEPTENOIC AND HEPTYNOIC ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS PHARMACIA CORPORATION (US) 2002-03-21 WO disclosed